Navigation Links
Study: Popular supplement quercetin does not enhance athletic performance
Date:9/3/2009

Athens, Ga. The antioxidant quercetin is increasingly being marketed as a supplement that boosts athletic performance, but a new University of Georgia study finds that it is no better than a placebo.

Professor Kirk Cureton, head of the department of kinesiology in the UGA College of Education, and his colleagues tested quercetin in a double-blind, placebo-controlled study that assessed a variety of measures, including the ability of muscles to synthesize energy, cycling performance, perceived exertion and strength loss following exercise. The researchers, whose results appear in the early online edition of the Journal of Applied Physiology, found that quercetin did not improve athletic performance in any of the measures they examined.

"We did not see any performance enhancing effect of quercetin," Cureton said. "To a certain extent that was disappointing because our hypothesis, based on previous studies in mice, was that we would see positive effects. But our findings are important because they suggest that results from the animal studies shouldn't be generalized to humans."

Quercetin is a naturally occurring antioxidant found in the skins of fruits, leafy vegetables, and berries, as well as in black tea, red wine and various fruit juices. It is sold as a supplement in nutrition stores and is an ingredient in sports drinks such as FRS Energy, which is promoted by cyclist Lance Armstrong.

In mice, quercetin has been shown to stimulate the production of mitochondria, which are the energy producing components of muscle cells and other tissue. One study found that mice supplemented with quercetin increased their running endurance by up to 37 percent.

In humans, however, the results have been mixed. An early and widely-cited study reported improvements in performance during a cycling time trial, but Cureton notes that data from the experimental group was not compared to the control group, making the statistical si
'/>"/>

Contact: Sam Fahmy
sfahmy@uga.edu
706-542-5361
University of Georgia
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Study: Oil speculators dominate open interest in oil futures
2. Study: Smoking may worsen malnutrition in developing nations
3. Study: Young Arctic muskoxen better at keeping warm than scientists thought
4. Study: Illegal fishing harming present and future New England groundfish fisheries
5. Yale study: Most polluted ecosystems recoverable
6. New study: Home energy savings are made in the shade
7. UNC study: Scientists identify chemical compound that may stop deadly brain tumors
8. Study: Health undervalued in reproductive rights debate
9. Study: Fluid buildup in lungs is part of the damage done by the flu
10. UNC study: Tinkering with the circadian clock can suppress cancer growth
11. Study: Excessive use of antiviral drugs could aid deadly flu

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...possess an ingenious mechanism for preventing oxyg...his is the new finding of a team of biologists tha...esearch institute in Flanders, Belgium, connected ...made this discovery by modifying the DNA of the in... this model organism, they have uncovered the exis...
(Date:11/20/2009)...COPD), a respiratory disease commonly known as chr...g cause of death worldwide. 600 million people li...d any real treatment or cure, Grace Parraga of Rob...rn Ontario in London, Canada, is using various ima...se. , Parraga is a scientist in the Imaging ...
(Date:11/19/2009)...al with an unwieldy name: 4-hydroxybutyrate (4-HB)...te-rape drug. , Now, a team of Ohio and Michiga...-HB is metabolized by the body. "This is new and i...fessor and chair of biological sciences at Michiga...earch team. "It may provide new clues on how to c...
Breaking Biology News(10 mins):Biologists discover bacterial defense mechanism against aggressive oxygen 2Gaining a better picture of lung disease 2Researchers begin to decipher metabolism of sexual assault drug 2SHPS Receives Re Accreditation from URAC for Multiple Health Management Programs 48486 1SHPS Receives Re Accreditation from URAC for Multiple Health Management Programs 48486 2Studies Report More Harmful Effects From BPA 48481 1Studies Report More Harmful Effects From BPA 48481 2Studies Report More Harmful Effects From BPA 48481 3Preliminary report on antidepressants published 48477 1Preliminary report on antidepressants published 48477 2
...effects of nutrition on blood disease porphyria ,... have uncovered a molecular explanation for the ep... in porphyria, the disease believed to have afflic...d for the loss of the American colonies in the Rev... of porphyria, a rare genetic blood disease which ...
...ch of genetic material may turn off the immune sup...h a vaccine, said researchers at Baylor College of...,s issue of the journal Science, Dr. Rong-Fu Wang,...herapy and Department of Immunology, and his colle...tion of a special group of T cells to suppress imm...
...d researcher who is now a chief of an immunology l...H) has rocked the boat in the past few years for t...system. , NIH,s Polly Matzinger has developed the ...is more concerned with damage detected on the basi...duction of foreign invaders, such as viruses. If M...
Other Biology News:Attacks of King George III's madness linked to key metabolism molecule 2Attacks of King George III's madness linked to key metabolism molecule 3Improving the potential of cancer vaccines 2Researchers seek to discover what really happens when a virus enters the body 2Researchers seek to discover what really happens when a virus enters the body 3
(Date:11/20/2009)..., , STOCKHOLM, November 20 /PRNewsw...that the European Investment Fund (EIF) has entere... The co-investment fund will be,managed by Karolin...s,portfolio of early-stage pharmaceutical and medi... 26.7 M Euros in the co-investment fund. The agree...
(Date:11/20/2009)... METTLER TOLEDO recently ... a free webinar, “The Role of Process Analyt... Engineering” on December 1, 2009. , ...ing the The Role of Process Analytical Technology...binar on December 1, Process Analytical Technolog...
(Date:11/19/2009)..., , SEATTLE, Nov. 19 /PRNewswire-FirstCall/...unced unaudited financial results for the third qu...hs ended September 30, 2009, Omeros reported a net...ared to a net loss of $7.4 million, or $2.54 per s...nths ended September 30, 2009, the Company reporte...
(Date:11/19/2009)..., , NEW YORK, Nov. 19 /PRNewswire-FirstCall...oday that it has sent the following letter to its ..., on October 30, 2009, of China Biopharmaceuticals...utical company based in the People,s Republic of C...nterest in Suzhou Eyre Pharmaceutical Co. Ltd., CH...
Breaking Biology Technology:Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 3Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3
...ov. 7 At an Amgen (Nasdaq: AMGN ),meeting of abo...rk City,today, several members of its senior manag... which includes delivering on its pipeline -- incl...ing in-line products and continuing,to pursue oper...kbuster products and today we have five,blockbuste...
...gistry is an observational study undertaken to eva...ervation (egg freezing) techniques, ROCKLAND, Mas...iliate,of Merck KGaA of Darmstadt, Germany, announ...perience (HOPE) Registry surrounding next week,s 6...roductive Medicine (ASRM).,The HOPE Registry is th...
...Md., Nov. 7 Human Genome Sciences,Inc. (Nasdaq: ...e Deutsche,Bank Biotech Boston Confab will be webc... (Logo: http://www.newscom.com/cgi-bin/prnh/2008...s, senior management team will present,a corporate... Eastern Time., Investors interested in listening...
Other Biology Technology:Amgen Positioned to Deliver Attractive Growth Over Next Five Years 2Amgen Positioned to Deliver Attractive Growth Over Next Five Years 3Amgen Positioned to Deliver Attractive Growth Over Next Five Years 4Amgen Positioned to Deliver Attractive Growth Over Next Five Years 5Amgen Positioned to Deliver Attractive Growth Over Next Five Years 6EMD Serono Launches Landmark Patient Registry for Egg Freezing 2EMD Serono Launches Landmark Patient Registry for Egg Freezing 3EMD Serono Launches Landmark Patient Registry for Egg Freezing 4
Mouse Anti-ROCK-1 (cleaved) Monoclonal Antibody, Unconjugated from BioVision
Mouse Anti-Plastin L Monoclonal Antibody, Unconjugated, Clone LPL4A.1 from Abcam
Mouse Anti-Chloramphenicol Acetyltransferase Monoclonal Antibody, Unconjugated, Clone CAT-1 from Abcam
... Cells are designed for use with the ProQuest Two-...203 contains deletions in the endogenous GAL4 and ...tems. The strain also has leu2 and trp1 mutations ...aV203 contains three GAL4 inducible reporter genes...
Biology Products: